EMPLOYER AND WORKPLACEINSURANCE AND ACCESS
As demand for GLP-1 weight-loss drugs like Ozempic surges, many employers and insurance companies are struggling with the high costs. Some companies that want to offer these benefits to employees are being forced to drop coverage altogether due to expense.